Service
PEI Biosimilar Initiative
Some drugs are made using living organisms or their cells. These drugs are called biologics. The first version of a biologic drug to be produced is called the originator or reference biologic. Biosimilars are highly similar versions of originator biologic drugs. They are produced when the patent expires on the originator biologic drug. Biosimilars are less expensive drugs that are reviewed by Health Canada to ensure they work in the same way as the originator biologic drugs and are equally effective. Through the PEI Biosimilar Initiative, coverage under PEI Pharmacare for certain biologic...
